Comments

Coeptis Therapeutics

COEPNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$0.286000
-0.003-1.05%
At close: Jul 19, 4:44 PM EDT
$0.283000
-0.0030-1.05%
After Hours: Jul 19, 4:44 PM EDT
15 minutes delayed
Coeptis Therapeutics (COEP) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$3.00
Consensus Price Target1
$5.67

Coeptis Therapeutics (NASDAQ:COEP) Stock, Analyst Ratings, Price Targets, Forecasts

Coeptis Therapeutics Holdings Inc has a consensus price target of $5.67 based on the ratings of 3 analysts. The high is $10 issued by EF Hutton on May 25, 2023. The low is $3 issued by Ladenburg Thalmann on September 22, 2023. The 3 most-recent analyst ratings were released by Ladenburg Thalmann, EF Hutton, and EF Hutton on September 22, 2023, May 25, 2023, and May 18, 2023, respectively. With an average price target of $6.33 between Ladenburg Thalmann, EF Hutton, and EF Hutton, there's an implied 2137.93% upside for Coeptis Therapeutics Holdings Inc from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Ladenburg Thalmann
EF Hutton
JonesTrading

1calculated from analyst ratings

Analyst Ratings for Coeptis Therapeutics

Buy NowGet Alert
09/22/2023Buy Now960.07%Ladenburg Thalmann
Aydin Huseynov
 → $3Initiates → BuyGet Alert
05/25/2023Buy Now3433.57%EF Hutton
Michael King
 → $10Assumes → BuyGet Alert
05/18/2023Buy Now2020.14%EF Hutton
Michael King
 → $6ReiteratesBuy → BuyGet Alert
05/10/2023Buy Now2020.14%EF Hutton
Michael King
 → $6Reiterates → BuyGet Alert
04/19/2023Buy Now1313.43%JonesTrading
Soumit Roy
 → $4Initiates → BuyGet Alert
04/05/2023Buy Now2020.14%EF Hutton
Michael King
 → $6Reiterates → BuyGet Alert
03/29/2023Buy Now2020.14%EF Hutton
Michael King
 → $6Reiterates → BuyGet Alert
12/13/2022Buy Now2020.14%EF Hutton
Michael King
 → $6Initiates → BuyGet Alert
12/12/2022Buy Now2020.14%EF Hutton
Michael King
 → $6Initiates → BuyGet Alert

FAQ

Q

What is the target price for Coeptis Therapeutics (COEP) stock?

A

The latest price target for Coeptis Therapeutics (NASDAQ:COEP) was reported by Ladenburg Thalmann on September 22, 2023. The analyst firm set a price target for $3.00 expecting COEP to rise to within 12 months (a possible 960.07% upside). 1 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Coeptis Therapeutics (COEP)?

A

The latest analyst rating for Coeptis Therapeutics (NASDAQ:COEP) was provided by Ladenburg Thalmann, and Coeptis Therapeutics initiated their buy rating.

Q

When was the last upgrade for Coeptis Therapeutics (COEP)?

A

There is no last upgrade for Coeptis Therapeutics

Q

When was the last downgrade for Coeptis Therapeutics (COEP)?

A

There is no last downgrade for Coeptis Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Coeptis Therapeutics (COEP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Coeptis Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Coeptis Therapeutics was filed on September 22, 2023 so you should expect the next rating to be made available sometime around September 22, 2024.

Q

Is the Analyst Rating Coeptis Therapeutics (COEP) correct?

A

While ratings are subjective and will change, the latest Coeptis Therapeutics (COEP) rating was a initiated with a price target of $0.00 to $3.00. The current price Coeptis Therapeutics (COEP) is trading at is $0.28, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch